News

More than €1 million — first results of reduced fees for micro-enterprises

In order to promote the long-term sustainability of the EPO, a budget-neutral fee policy reform has been implemented, which includes targeted fee discounts to improve access to the patent system for underrepresented micro-entities through moderate fee adjustments.

The revised fee structure, effective from 1 April 2024, offers micro-enterprises, natural persons, non-profit organizations, universities, and public research organizations a 30% reduction on all main fees in the patent granting process. To date, eligible micro-entities have saved more than €1 million through this scheme, benefiting over 1,900 applications and resulting in over 4,000 reduced fees. Over 70% of all requests come from users based in EPC Member States, with the top ten countries being Italy, Germany, UK, France, Switzerland, Spain, Finland, Poland, Sweden, and Austria. The overall percentage of beneficiaries among applicants remains at 2%.

Through targeted fee discounts, the EPO assists underrepresented key players in the innovation ecosystem in safeguarding their most valuable inventions at a lower cost, which have resulted from significant investments of time and effort over many years. These fee discounts are just one part of complementary measures aimed at improving the accessibility of the patent system. These measures include established language-related fee discounts as well as the Deep Tech Finder — a free digital tool designed to help investors identify and evaluate European startups that are bringing inventions to market in critical technology areas.

The fee reduction for micro-entities is applicable to new and pending applications, as long as the micro-entity has not filed five or more previous applications within the past five years. It can be combined with other fee reductions, especially language-related fee reductions.

pat

Recent Posts

Tracking deadlines is an essential aspect of patent prosecution

Dear colleagues, we would like to inform you about the weekends and holidays in 2025…

1 неделя ago

October 24-26, 2024 | Patentica took part in AIPLA 2024 Annual Meeting

Maria Nilova and Nikolai Kovkov from Patentica recently participated in the AIPLA 2024 Annual Meeting…

4 недели ago

Patentica participated in the LES USA-Canada Annual Meeting | October 20-23, 2024

Maria Nilova and Nikolai Kovkov from Patentica recently took part in the LES USA-Canada Annual…

1 месяц ago

4,667 intellectual property infringements were identified in the EAEU in 2023

On October 9, a meeting of the Advisory Committee on Intellectual Property under the Board…

1 месяц ago

Rospatent’s clarifications on the Statute on Fees as amended

The Russian Patent and Trademark Office has issued clarifications regarding some typical questions on the…

2 месяца ago

Revocation of Patent RU 2421238 Related to Liraglutide Composition (Sun Pharmaceuticals Industries, Ltd (IN) v. Novo Nordisk A/S (DK))

Patentica’s patent attorneys, Victor Lisovenko and Ksenia Emelianova have successfully represented Sun Pharmaceuticals in opposing…

2 месяца ago